Asia Pacific Single-Use Negative Pressure Wound Therapy Devices Market

Market Introduction

Negative pressure wound therapy (NPWT) is used for managing wide range of wound types such as traumatic, hard-to-heal, chronic wounds. It is also used to manage wounds that are covered with flaps or a skin graft. This therapy is transformed into a medical device such as a single-use NPWT device, and it is a small pocket-sized battery-operated device. As the name suggests, these are disposable and portable devices generally used for outpatient care.

Asia Pacific Single-Use Negative Pressure Wound Therapy Devices Strategic Insights

Strategic insights for the Asia Pacific Single-Use Negative Pressure Wound Therapy Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Single-Use Negative Pressure Wound Therapy Devices Report Scope

Asia Pacific Single-Use Negative Pressure Wound Therapy Devices Regional Insights

The geographic scope of the Asia Pacific Single-Use Negative Pressure Wound Therapy Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Asia Pacific single-use negative pressure wound therapy market is expected to reach US$ 151.34 million by 2028 from US$ 80.68 million in 2021; it is estimated to grow at a CAGR of 9.4% from 2021 to 2028. The growth of the market is attributed to rising developments in the global health sector and increasing cases of burn injuries. However, the market is expected to have a slow growth rate due to the lack of effective reimbursement policies for wound care.

Chronic wound management products are an essential requirement in the healthcare sector. The research activities carried out in the last few years have resulted in innovative products and solutions in the wound management market. For instance, in February 2017, Centurion launched a new wound irrigation system, IRIG-8, for acute wound management in emergency rooms. The launch of more such innovative and effective products is expected to fuel the single-use negative pressure wound therapy devices market during the forecast period. Also, the healthcare sector has been undergoing rapid transformations from the last several years, with the growing acceptance of advanced technologies. Technology-enabled care (TEC) solutions are being adopted in emerging economies with an increase in the need for better healthcare facilities. A surge in the aging population, incidence of chronic illnesses, and advancements in pediatric care are the primary factors driving the global healthcare sector. Significant investments in R&D by various healthcare companies, governments, and research organizations and the ongoing improvements in reimbursement policies meant for various medical procedures are expected to fuel the growth of the healthcare sector in the coming years. Moreover, the increasing number of effective regulations by government bodies is likely to result in better and reliable healthcare facilities, ensuring quality care and patient safety, and mitigating fraud and cyber-threats. Such developments in the healthcare sector worldwide are likely to provide significant growth opportunities for market players for advanced wound care devices, such as single-use negative pressure wound therapy devices.

Countries in Asia Pacific are facing challenges due to the increasing incidence of COVID-19. Several measures have been implemented to contain the spread of COVID-19, which have resulted in significant operational disruption for many companies, including the companies operating in the healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient for private hospital chains. To relieve healthcare systems, many clinics have been postponing diagnosis and treatment apart from COVID-19. To minimize the exposure risk during pandemic situations, patients use disposable devices rather than conventional NPWT devices. Due to health concerns, people prefer to use single-use products to manage chronic and acute wounds. This factor is supporting the growth of the market during the pandemic.

Key Market Segments

The Asia Pacific single-use negative pressure wound therapy devices market, based on wound type, was segmented into surgical, traumatic, diabetic foot, sports injuries, venous leg ulcers, and others. In 2020, the traumatic segment held the largest share of the market, and it is also expected to grow at the fastest rate during the coming years.

Based on end user, the Asia Pacific single-use negative pressure wound therapy devices market was segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2020, the hospitals segment held the largest share of the market. In addition, the demand for hospitals is also expected to grow at the fastest rate during the coming years due to the availability of advanced techniques for single-use negative pressure wound therapy devices.

Major Sources and Companies Listed

A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific single-use negative pressure wound therapy market are the Association for Burns Injuries Singapore (ABIS), Australian Medical Association (AMA), and Japan Society for Surgical Wound Care (JSSWC).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific single-use negative pressure wound therapy market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific single-use negative pressure wound therapy market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific single-use negative pressure wound therapy market.

ASIA PACIFIC SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION

By Wound Type

• Surgical
• Traumatic
• Diabetic Foot
• Sports Injuries
• Venous Leg Ulcers
• Others

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centres
• Others

By Country

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Company Profiles

• Cardinal Health Inc
• ConvaTec Group Plc
• Carilex Medical
• Genadyne Biotechnologies, Inc.
• Lohmann & Rauscher GmbH & Co. KG
• Medela AG
• Mölnlycke Health Care AB
• PAUL HARTMANN AG
• Smith & Nephew